Abstract:Carbon nano-dots (C-Dots) possess great benign properties, making them ideal for use in biomedical fields, especially due to their high aqueous solubility, outstanding photoluminescence (PL), favorable biocompatibility, low toxicity, chemical inertness, and easy functionalization properties. Herein, the C-Dots with sizes of about 2.4 ± 0.9 nm and containing the groups -OH, C[double bond, length as m-dash]C and C[double bond, length as m-dash]O, were shown to prolong the lag phase of human insulin (HI) fibrillation following a dose-dependent manner in an in vitro study. The spontaneous growth of fibrils after a lag phase was accompanied by exothermic heat, determined by isothermal titration calorimetry (ITC), demonstrating the inhibitory effect of C-Dots. Moreover, as the dose of C-Dots was increased to 4 mg mL-1, the fibrillation process could be totally deterred for more than half a month. However, the deterrent effect of the C-Dots on HI fibrillation disappeared when just a few fibril seeds were added. This is because the association constant of HI monomers interacting with fibril seeds (K2: 1.56 × 105 M-1) is much larger than that with C-Dots (K2: 8.28 × 103 M-1), as determined by analyzing the ITC results. An ''active-site targeted'' inhibitory mechanism has also been proposed. The "active site" is mainly on the B-chain of HI, and the ITC results show that the binding between the C-Dots and HI monomers is mainly driven by the electrostatic force. This is the first time that the anti-fibrillation mechanism in the presence of C-Dots has been analyzed by ITC. These results indicate that ITC is a promising approach for comprehensively clarifying the mechanisms of protein fibrillation inhibition.

Bifunctional Carbon Dots for Cell Imaging and Inhibition of Human Insulin Fibrillation in the Whole Aggregation Process.

Active Site-Targeted Carbon Dots for the Inhibition of Human Insulin Fibrillation

High-Oxygen-Content Carbon Dots As a High-Efficiency Inhibitor of Human Insulin Aggregation.

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

Molecular Mechanisms of the Ultra-Strong Inhibition Effect of Oxidized Carbon Dots on Human Insulin Fibrillation.

Regulation mechanism of human insulin fibrillation by L-lysine Carbon dots: low concentration accelerates but high concentration inhibits the fibrillation process

The Effects of A Series of Carbon Dots on Fibrillation and Cytotoxicity of Human Islet Amyloid Polypeptide

Regulation Mechanism of Human Insulin Fibrillation Byl-Lysine Carbon Dots: Low Concentration Accelerates but High Concentration Inhibits the Fibrillation Process

Inhibition mechanism of human insulin fibrillation by Bodipy carbon polymer dots and photothermal defibrillation effect of Bodipy carbon polymer dots modified by ThT

Zn-doped Cu2S quantum dots as new high-efficiency inhibitors against human insulin fibrillation based on specific electrostatic interaction with oligomers

Nontoxic Black Phosphorus Quantum Dots Inhibit Insulin Amyloid Fibrillation at an Ultralow Concentration

Dopamine-Conjugated Carbon Dots Inhibit Human Calcitonin Fibrillation

Hydrothermal synthesis of nitrogen-doped carbon dots with real-time live-cell imaging and blood-brain barrier penetration capabilities

Dual Functional Amphiphilic Sugar-Coated AIE-active Fluorescent Organic Nanoparticles for the Monitoring and Inhibition of Insulin Amyloid Fibrillation Based on Carbohydrate-Protein Interactions.

Rational Design of Nitrogen-Doped Carbon Dots for Inhibiting β-Amyloid Aggregation

Fluorescent Silicon Nanoparticles Inhibit the Amyloid Fibrillation of Insulin

Target-triggered and Controlled Release Plasmon-Enhanced Fluorescent AIE Probe for Conformational Monitoring of Insulin Fibrillation.

Efficient Encapsulation of Insulin by Giant Macrocycle as a Powerful Approach to the Inhibition of Its Fibrillation

Synthesis of Bifunctional Carbon Quantum Dots for Bioimaging and Anti-Inflammation

Facile Synthesis of N, B-Doped Carbon Dots and Their Application for Multisensor and Cellular Imaging

Supramolecular Nanoparticles of Insulin and Pentapeptide for Inhibition of Fibrillation and Controlled Release